SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor drug development in depression? Does mismatch negativity have utility for NMDA receptor drug development in depression?

Rapid antidepressant effects associated with ketamine have shifted the landscape for the

PDF) Neuroprogression in schizophrenia: Pathways underpinning

PDF) Does mismatch negativity have utility for NMDA receptor drug

SciELO - Brazil - Does mismatch negativity have utility for NMDA

Frontiers Presynaptic NMDA receptors and spike timing-dependent

NMDA receptor-dependent long-term depression in the lateral

DAPK1 Interaction with NMDA Receptor NR2B Subunits Mediates Brain

Summary of the mechanisms of how N-methyl-D-aspartate receptor

a href=

NMDA receptor subunit diversity: impact on receptor properties

SciELO - Brazil - Does mismatch negativity have utility for NMDA

Alteration of NMDA receptor trafficking as a cellular hallmark of

PDF) Neuroprogression in schizophrenia: Pathways underpinning

The NMDA receptor antagonist ketamine impairs and delays context